DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C0432333 | Abnormal dermatoglyphic pattern | DHCR7 | 1717 | 7-dehydrocholesterol reductase | Q9UBM7 |
C0026769 | Multiple Sclerosis | DHCR7 | 1717 | 7-dehydrocholesterol reductase | Q9UBM7 |
C2239176 | Liver carcinoma | DHCR7 | 1717 | 7-dehydrocholesterol reductase | Q9UBM7 |
C0349506 | Photosensitivity of skin | DHCR7 | 1717 | 7-dehydrocholesterol reductase | Q9UBM7 |
C0024530 | Malaria | PGLS | 25796 | 6-phosphogluconolactonase | O95336 |
C0029459 | Osteoporosis, Senile | PGLS | 25796 | 6-phosphogluconolactonase | O95336 |
C0751406 | Post-Traumatic Osteoporosis | PGLS | 25796 | 6-phosphogluconolactonase | O95336 |
C0006142 | Malignant neoplasm of breast | PGLS | 25796 | 6-phosphogluconolactonase | O95336 |
C3642345 | Luminal A Breast Carcinoma | PGLS | 25796 | 6-phosphogluconolactonase | O95336 |
C0001787 | Osteoporosis, Age-Related | PGLS | 25796 | 6-phosphogluconolactonase | O95336 |
C0029456 | Osteoporosis | PGLS | 25796 | 6-phosphogluconolactonase | O95336 |
C0678222 | Breast Carcinoma | PGLS | 25796 | 6-phosphogluconolactonase | O95336 |
C2239176 | Liver carcinoma | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C0699885 | Carcinoma of bladder | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C0006826 | Malignant Neoplasms | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C1306459 | Primary malignant neoplasm | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C0017638 | Glioma | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C1134719 | Invasive Ductal Breast Carcinoma | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C0023903 | Liver neoplasms | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C0005684 | Malignant neoplasm of urinary bladder | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C0235974 | Pancreatic carcinoma | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C0030297 | Pancreatic Neoplasm | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C0678222 | Breast Carcinoma | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C0027651 | Neoplasms | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
C0242379 | Malignant neoplasm of lung | PFKFB4 | 5210 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024